These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 9348243

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
    Zhao XY, Ly LH, Peehl DM, Feldman D.
    Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
    [Abstract] [Full Text] [Related]

  • 4. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone.
    Lee C, Sutkowski DM, Sensibar JA, Zelner D, Kim I, Amsel I, Shaw N, Prins GS, Kozlowski JM.
    Endocrinology; 1995 Feb; 136(2):796-803. PubMed ID: 7530653
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro.
    Okamoto M, Lee C, Oyasu R.
    Cancer Res; 1997 Jan 01; 57(1):141-6. PubMed ID: 8988055
    [Abstract] [Full Text] [Related]

  • 6. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line.
    Guillemette C, Hum DW, Bélanger A.
    Endocrinology; 1996 Jul 01; 137(7):2872-9. PubMed ID: 8770908
    [Abstract] [Full Text] [Related]

  • 7. Autocrine effect of DHT on FGF signaling and cell proliferation in LNCaP cells: role of heparin/heparan-degrading enzymes.
    Kassen AE, Sensibar JA, Sintich SM, Pruden SJ, Kozlowski JM, Lee C.
    Prostate; 2000 Jul 01; 44(2):124-32. PubMed ID: 10881022
    [Abstract] [Full Text] [Related]

  • 8. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells.
    Robbins SE, Shu WP, Kirschenbaum A, Levine AC, Miniati DN, Liu BC.
    Prostate; 1996 Dec 01; 29(6):362-70. PubMed ID: 8977633
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells.
    Sherwood ER, Van Dongen JL, Wood CG, Liao S, Kozlowski JM, Lee C.
    Br J Cancer; 1998 Mar 01; 77(6):855-61. PubMed ID: 9528825
    [Abstract] [Full Text] [Related]

  • 10. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
    Hobisch A, Ramoner R, Fuchs D, Godoy-Tundidor S, Bartsch G, Klocker H, Culig Z.
    Clin Cancer Res; 2001 Sep 01; 7(9):2941-8. PubMed ID: 11555613
    [Abstract] [Full Text] [Related]

  • 11. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP.
    Wang QF, Tilly KI, Tilly JL, Preffer F, Schneyer AL, Crowley WF, Sluss PM.
    Endocrinology; 1996 Dec 01; 137(12):5476-83. PubMed ID: 8940374
    [Abstract] [Full Text] [Related]

  • 12. The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP.
    Olea N, Sakabe K, Soto AM, Sonnenschein C.
    Endocrinology; 1990 Mar 01; 126(3):1457-63. PubMed ID: 2307113
    [Abstract] [Full Text] [Related]

  • 13. Biological effects of sex hormone-binding globulin on androgen-induced proliferation and androgen metabolism in LNCaP prostate cells.
    Damassa DA, Lin TM, Sonnenschein C, Soto AM.
    Endocrinology; 1991 Jul 01; 129(1):75-84. PubMed ID: 2055206
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor binding protein-3 is regulated by dihydrotestosterone and stimulates deoxyribonucleic acid synthesis and cell proliferation in LNCaP prostate carcinoma cells.
    Martin JL, Pattison SL.
    Endocrinology; 2000 Jul 01; 141(7):2401-9. PubMed ID: 10875240
    [Abstract] [Full Text] [Related]

  • 15. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.
    Berenguer C, Boudouresque F, Dussert C, Daniel L, Muracciole X, Grino M, Rossi D, Mabrouk K, Figarella-Branger D, Martin PM, Ouafik L.
    Oncogene; 2008 Jan 17; 27(4):506-18. PubMed ID: 17637748
    [Abstract] [Full Text] [Related]

  • 16. Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cells.
    Fong CJ, Sutkowski DM, Braun EJ, Bauer KD, Sherwood ER, Lee C, Kozlowski JM.
    J Urol; 1993 May 17; 149(5):1190-4. PubMed ID: 7683344
    [Abstract] [Full Text] [Related]

  • 17. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
    Kim IY, Zelner DJ, Sensibar JA, Ahn HJ, Park L, Kim JH, Lee C.
    Exp Cell Res; 1996 Jan 10; 222(1):103-10. PubMed ID: 8549651
    [Abstract] [Full Text] [Related]

  • 18. Regulation of androgen receptor by androgen and epidermal growth factor in a human prostatic cancer cell line, LNCaP.
    Mizokami A, Saiga H, Matsui T, Mita T, Sugita A.
    Endocrinol Jpn; 1992 Jun 10; 39(3):235-43. PubMed ID: 1425449
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO, Chun JY, Nadiminty N, Lou W, Gao AC.
    Prostate; 2007 May 15; 67(7):764-73. PubMed ID: 17373716
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.